Search results
Results from the WOW.Com Content Network
MINNEAPOLIS - The American Academy of Neurology (AAN), has issued a guideline providing recommendations for treating movement symptoms, called motor symptoms, in people with early Parkinson’s disease.
This guideline covers diagnosing and managing Parkinson’s disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.
Parkinson disease is characterized by a progressive loss of dopamine-producing neurons in the basal ganglia, particularly in the substantia nigra, 2 and development of Lewy bodies in the...
This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.
The American Parkinson Disease Association (APDA) is here to provide you with the necessary information and resources to better manage Parkinson’s disease (PD).
This is a summary of the American Academy of Neurology (AAN) guideline, “Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline,” which was published in Neurology ® online on November 15, 2021, and appears in the November 16, 2021,
Since the publication of NICE’s 2006 guideline on Parkinson’s disease, there have been advances in several areas of the clinical management of Parkinson’s disease, including surgery and drug treatments. This guideline will investigate developments in these areas and update the advice given in NICE guideline CG35.
Since 2002, many new medications and new formulations of older medications have become available for PD treatment. The goal of this guideline is to review the current evidence on initial dopaminergic treatment of motor symptoms in early-stage PD and provide guidance to clinicians.
It is hoped that this guideline on Parkinson’s disease will be of considerable help to those involved at all levels in these difficult management decisions. The guideline has been produced using standard NICE methodology and is therefore based on a thorough search for best evidence.
This article summarises the most recent update to the National Institute for Health and Care Excellence (NICE) guideline for the diagnosis and management of Parkinson’s disease in adults.2 This NICE guideline provides an update on most aspects of managing Parkinson’s disease, incorporating knowledge generated by a series of recent, large ...